A researcher at the Fred Hutchinson Cancer Research Center received the first $50,000 award of a new funding program jointly developed by the center and the Washington Research Foundation (WRF) to support the development of a new screening method to identify emerging therapies for idiopathic pulmonary fibrosis (IPF). The awardee, Taran Gujral, PhD, and colleagues previously had developed an artificial-intelligence (AI)-based therapy screening method that allowed them to recreate the complex environment of cells that…

You must be logged in to read/download the full post.